| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1445-5994.1990.TB01025.X |
| P698 | PubMed publication ID | 2115326 |
| P2093 | author name string | S Gordon | |
| C N Chesterman | |||
| S A Krilis | |||
| W Shi | |||
| B H Chong | |||
| P433 | issue | 3 | |
| P921 | main subject | anticoagulant | Q215118 |
| P304 | page(s) | 231-236 | |
| P577 | publication date | 1990-06-01 | |
| P1433 | published in | Australian and New Zealand journal of medicine | Q27709236 |
| P1476 | title | Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population | |
| P478 | volume | 20 |
| Q28195850 | 21-year-old patient with myocardial infarct, transient cerebral ischemia and thrombocytopenia |
| Q58768948 | Acute adrenal insufficiency due to adrenal hemorrhage complicating colorectal surgery: Report of two cases and correlation with the antiphospholipid antibody syndrome |
| Q90377963 | Acute myocardial infarction due to antiphospholipid antibody syndrome in a young pregnant woman |
| Q41904864 | Acute thrombotic occlusion of right coronary and left circumflex coronary arteries in a patient with antiphospholipid syndrome: successful stent implantation |
| Q37628253 | Anesthetic management of antiphospholipid syndrome patients who underwent cardiac surgery: three cases report |
| Q108395894 | Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor |
| Q79245648 | Anticardiolipin antibodies in various diseases in Taiwan: a retrospective analysis |
| Q30355477 | Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio. |
| Q35756040 | Antiphospholipid Syndrome during pregnancy: the state of the art |
| Q73086663 | Antiphospholipid antibodies and the antiphospholipid antibody syndrome |
| Q33944344 | Antiphospholipid antibodies during 6-month treatment with infliximab: a preliminary report. |
| Q73815951 | Antiphospholipid antibodies in children without and in adults with and without thrombophilia |
| Q41682862 | Antiphospholipid antibodies or not? The role of beta 2 glycoprotein 1 in autoantibody-mediated pregnancy loss |
| Q28195585 | Antiphospholipid syndrome |
| Q35134524 | Arterial thromboembolism in pregnancy |
| Q34775689 | Autoantibodies and Sjogren's Syndrome in multiple sclerosis, a reappraisal |
| Q37210831 | Bentall Surgery in a Patient with Cold Agglutinin and Antiphospholipid Antibody: Double Trouble |
| Q44787262 | Central serous chorioretinopathy and antiphospholipid antibodies--results of a pilot study |
| Q35108608 | Chorea associated with high titers of antiphospholipid antibodies in the absence of antiphospholipid antibody syndrome |
| Q40917049 | Contraceptive choices in women with coagulation disorders |
| Q40841563 | Current insights into the "antiphospholipid" syndrome: clinical, immunological, and molecular aspects |
| Q36434134 | Do antiphospholipid antibodies develop for a purpose? |
| Q34434855 | Hematologic genetic testing in high-risk patients before knee arthroplasty: a pilot study. |
| Q78081224 | Hypercoagulable states in patients with retinal venous occlusion |
| Q73352712 | Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin |
| Q33379907 | Immunology and Clinical Importance of Antiphospholipid Antibodies |
| Q47292307 | Increased incidence of hypercoagulability in patients with leg ulcers caused by leukocytoclastic vasculitis |
| Q37738699 | Intensity of warfarin coagulation in the antiphospholipid syndrome |
| Q33498334 | Isolation and purification of anticardiolipin antibody from plasma of a patient with antiphospholipid syndrome: induced generation of platelet thromboxane A2 synthesis |
| Q40603707 | Laboratory assessment of circulating anticoagulants. |
| Q34057664 | Long-term follow-up of ischaemic retinopathy in the antiphospholipid syndrome with lupus-like disease |
| Q51332462 | Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjögren's syndrome. |
| Q33453074 | Platelet Factor 4/Heparin Antibodies in Blood Bank Donors |
| Q36977996 | Prevalence and Resolution of Lupus Anticoagulant in Children |
| Q48453807 | Prevalence and clinical features of dementia associated with the antiphospholipid syndrome and circulating anticoagulants |
| Q51006300 | Prevalence and clinical significance of antiphospholipid antibodies in heart valve disease: a case-control study. |
| Q34674429 | Primary anti-phospholipid antibody syndrome (APS): current concepts |
| Q73694791 | Primary antiphospholipid syndrome in stroke in the young |
| Q59354270 | Role of Infectious Diseases in the Antiphospholipid Syndrome (Including Its Catastrophic Variant) |
| Q53096573 | Role of anticardiolipin antibodies in the pathogenesis of prosthetic valve thrombosis: An observational study. |
| Q42646992 | Subsequent Thrombotic Outcomes in Patients with Ischemic Stroke with Antiphospholipid Antibody Positivity |
| Q30243901 | Systematic review of case reports of antiphospholipid syndrome following infection. |
| Q33766710 | Testing for and clinical significance of anticardiolipin antibodies |
| Q35966558 | The role of antiphospholipid antibodies in stroke. |
| Q55547645 | Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies. |
| Q26739950 | Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay |
| Q35554567 | Treatment with tumour necrosis factor alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies |
| Q81153272 | [Cerebral infarction of arterial origin and haematological causation: the Lausanne experience and a review of the literature] |
| Q52839369 | [Choosing wisely recommendations in rheumatology : One year after their first publication]. |
Search more.